Ergoteles LLC Ptc Therapeutics, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $1.09 Million - $1.59 Million	26,945 Added 174.47%	42,389 $1.72 Million
Q1 2023 May 10, 2023	SELL	$38.16 - $48.86 $1.03 Million - $1.31 Million	-26,899 Reduced 63.53%	15,444 $748,000
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $354,479 - $579,239	10,572 Added 33.28%	42,343 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $290,020 - $373,180	6,930 Added 27.9%	31,771 $1.6 Million
Q2 2022 Aug 12, 2022	BUY	$25.6 - $45.23 $133,145 - $235,241	5,201 Added 26.48%	24,841 $995,000
Q1 2022 May 13, 2022	SELL	$33.33 - $44.6 $320,634 - $429,052	-9,620 Reduced 32.88%	19,640 $733,000
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $1.03 Million - $1.22 Million	29,260 New	29,260 $1.17 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.